| Financial Year |
March 31 2023 |
| Monetary Funds |
609,001,452.07 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
89,868,806.69 |
| Accounts Receivable |
339,018,234.45 |
| Advances to Suppliers |
41,664,320.72 |
| Other Receivables |
2,268,742.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
444,229,525.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
103,474.91 |
| Total Current Assets |
1,615,035,714.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
550,987,201.63 |
| Under-construction Projects |
67,077,193.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
113,176,165.78 |
| R&D expenses |
-- |
| Goodwill |
360,330,749.17 |
| Long-Term Deferred and Prepaid Expenses |
1,522,528.19 |
| Deferred Income Tax Assets |
56,845,690.17 |
| Other Non-Current Assets |
182,913,693.02 |
| Sub-Total of Non-Current Assets |
1,342,742,268.31 |
| Total Assets |
2,957,777,982.84 |
| Short-Term Loans |
99,261,097.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
198,486,023.41 |
| Accounts Payable |
214,135,219.01 |
| Accounts Received In Advance |
41,204.20 |
| Employee Compensation Payable |
22,446,917.38 |
| Taxes Payable |
28,841,648.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,921,936.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,850,458.97 |
| Other Current Liabilities |
22,181,688.54 |
| Sub-Total of Current Liabilities |
624,817,703.89 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
52,883,977.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
103,987,730.18 |
| Total Liabilities |
728,805,434.07 |
| Paid-In Capital(Or Share Stock) |
755,378,818.00 |
| Capital Surplus |
434,538,285.37 |
| Surplus Reserve |
148,110,269.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
890,945,175.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,228,972,548.77 |
| Owner's Equity（Stockholder's Equity） |
2,228,972,548.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,957,777,982.84 |
